Clarithromycin mitigates radiation pneumonitis in patients with lung cancer treated with stereotactic body radiotherapy
Journal of Thoracic Disease Feb 05, 2018
Takeda A, et al. - Radiation pneumonitis is a critical pulmonary toxicity after irradiation of the lung. Whether clarithromycin (CAM) mitigated radiation pneumonitis following stereotactic body radiotherapy (SBRT) for lung cancer, was investigated. It was shown that administration of CAM resulted in mitigation of radiation pneumonitis following SBRT.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
